Su-Hyun Lee
News
14.03.2016
Merck Initiates Phase III Study of MSB11022
Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This […]
21.01.2021
Asclepion Laser Technologies: Innovative partner for your aesthetic practice
To develop innovative and successful products is the ethos of Asclepion Laser Technologies. Therefore, the company invests intensively in research and medical practice. The goal is to make the advantages […]
09.10.2015
SOLTA MEDICAL RAIDS DISTRIBUTOR OF COUNTERFEIT THERMAGE® MACHINES
Solta Medical, Inc. (“Solta“), a wholly-owned subsidiary of Valeant Pharmaceuticals International, Inc., announced today a brand enforcement action taken against a distributor of counterfeit Thermage® machines. Solta is […]